The 6 most recent market catalysts affecting $IVA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 15, 2026
Corporate Catalyst
Bullish
Impact 55
Guggenheim Maintains Buy on Inventiva, Raises Price Target to $14
Guggenheim analyst Seamus Fernandez maintained a 'Buy' rating on Inventiva and raised the price target from $11 to $14. This action signals a more optimistic outlook from a notable…
Sep 9, 2026
Corporate Catalyst
Bullish
Impact 85
InnovAge Holding shares are trading higher after the company reported better-than-expected Q4 sales results and issued FY27 sales guidance above estimates. Also, Keybanc maintained an Overweight rating on the stock and raised its price target from $13 to $14.
This headline is a strong positive catalyst for InnovAge Holding (IVA). The better-than-expected Q4 sales and the issuance of FY27 sales guidance above estimates signal robust oper…
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 75
Inventiva Completes Final 72-Week NATiV3 Patient Visit With 1,419 Patients Enrolled, Topline Results Expected Q4 2026
Inventiva has announced the completion of the final 72-week patient visit for its NATiV3 Phase 3 clinical trial for lanifibranor, a drug targeting MASH. This is a crucial operation…
Aug 31, 2026
Corporate Catalyst
Neutral
Impact 55
Inventiva Appoints Chris Benecchi As COO
The appointment of a Chief Operating Officer (COO) like Chris Benecchi at Inventiva (IVA) is a corporate catalyst that typically signals a focus on improving internal operations, e…
Jul 30, 2026
Corporate Catalyst
Neutral
Impact 75
Inventiva Reports No Revenue During H1, Compared To €4.5M YoY
Inventiva, a clinical-stage biopharmaceutical company, disclosed that it generated no revenue in the first half of 2026, a stark contrast to the €4.5 million reported in the first …
Jul 17, 2026
Corporate Catalyst
Neutral
Impact 55
Cantor Fitzgerald Initiates Coverage On Inventiva with Overweight Rating
Cantor Fitzgerald analyst Prakhar Agrawal initiated coverage on Inventiva (IVA) with an Overweight rating. This event is significant because new analyst coverage, especially with a…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.